Przejdź do zawartości
Merck

NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway.

The Journal of cell biology (2011-05-11)
Sandra Habbig, Malte P Bartram, Roman U Müller, Ricarda Schwarz, Nikolaos Andriopoulos, Shuhua Chen, Josef G Sägmüller, Martin Hoehne, Volker Burst, Max C Liebau, H Christian Reinhardt, Thomas Benzing, Bernhard Schermer
ABSTRAKT

The conserved Hippo signaling pathway regulates organ size in Drosophila melanogaster and mammals and has an essential role in tumor suppression and the control of cell proliferation. Recent studies identified activators of Hippo signaling, but antagonists of the pathway have remained largely elusive. In this paper, we show that NPHP4, a known cilia-associated protein that is mutated in the severe degenerative renal disease nephronophthisis, acts as a potent negative regulator of mammalian Hippo signaling. NPHP4 directly interacted with the kinase Lats1 and inhibited Lats1-mediated phosphorylation of the Yes-associated protein (YAP) and TAZ (transcriptional coactivator with PDZ-binding domain), leading to derepression of these protooncogenic transcriptional regulators. Moreover, NPHP4 induced release from 14-3-3 binding and nuclear translocation of YAP and TAZ, promoting TEA domain (TEAD)/TAZ/YAP-dependent transcriptional activity. Consistent with these data, knockdown of NPHP4 negatively affected cellular proliferation and TEAD/TAZ activity, essentially phenocopying loss of TAZ function. These data identify NPHP4 as a negative regulator of the Hippo pathway and suggest that NPHP4 regulates cell proliferation through its effects on Hippo signaling.

MATERIAŁY
Numer produktu
Marka
Opis produktu

Supelco
Sepharose CL-4B, Cross-linked
Sigma-Aldrich
GeneJuice® Transfection Reagent, Non-lipid based chemical transfection reagent optimized for maximum transfection efficiency, ease-of-use, and minimal cytotoxicity on a wide variety of mammalian cells.